Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
2/1/2024 | $20.00 | Neutral | Goldman | |
1/30/2024 | $18.00 | Buy | Deutsche Bank | |
1/2/2024 | $28.00 → $34.00 | Neutral → Buy | B. Riley Securities | |
12/15/2023 | $14.00 → $15.00 | Market Perform → Underperform | BMO Capital Markets | |
7/18/2023 | $19.00 | Outperform → Market Perform | BMO Capital Markets | |
5/8/2023 | $20.00 | Mkt Perform → Mkt Outperform | JMP Securities | |
1/30/2023 | Mkt Perform | JMP Securities | ||
1/4/2023 | $22.00 → $19.00 | Buy → Hold | Deutsche Bank |
Independence Realty Trust, Inc. (NYSE:IRT) ("IRT") announced that today IRT's board of directors declared a quarterly dividend of $0.16 per share of IRT common stock, payable on October 18, 2024 to stockholders of record at the close of business on September 30, 2024. About Independence Realty Trust, Inc. Independence Realty Trust, Inc. (NYSE:IRT) is a real estate investment trust that owns and operates multifamily communities, across non-gateway U.S. markets including Atlanta, GA, Dallas, TX, Denver, CO, Columbus, OH, Indianapolis, IN, Raleigh-Durham, NC, Oklahoma City, OK, Nashville, TN, Houston, TX, and Tampa, FL. IRT's investment strategy is focused on gaining scale near major employm
Independence Realty Trust, Inc. ("IRT") (NYSE:IRT), a multifamily apartment REIT, today announced the closing of its previously announced underwritten public offering of 11,500,000 shares of common stock at a public offering price of $19.75 per share, including 1,500,000 shares sold pursuant to the exercise in full of the underwriters' option to purchase additional shares of common stock. In connection with the offering, IRT entered into forward sale agreements with Citigroup. Citigroup, KeyBanc Capital Markets Inc., RBC Capital Markets, LLC, BofA Securities, Barclays, BMO Capital Markets Corp., Baird, Capital One Securities, Inc., Citizens JMP Securities, LLC, Jefferies LLC, Regions Secu
BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the appointment of Julie Eastland, an experienced biotechnology and financial executive, to Lantheus' Board of Directors ("Board"), effective as of September 3, 2024. As an independent director, Ms. Eastland will serve as a member of the Board's Audit Committee. Following the appointment of Ms. Eastland, the Board will be comprised of ten directors, eight of whom are independent. "We are thrilled to welcome Julie Eastland t
SC 13D - DYNAVAX TECHNOLOGIES CORP (0001029142) (Subject)
SC 13G/A - DYNAVAX TECHNOLOGIES CORP (0001029142) (Subject)
SC 13G/A - INDEPENDENCE REALTY TRUST, INC. (0001466085) (Subject)
4 - ALPHA & OMEGA SEMICONDUCTOR Ltd (0001387467) (Issuer)
4 - ALPHA & OMEGA SEMICONDUCTOR Ltd (0001387467) (Issuer)
4 - ALPHA & OMEGA SEMICONDUCTOR Ltd (0001387467) (Issuer)
Goldman initiated coverage of Dynavax with a rating of Neutral and set a new price target of $20.00
Deutsche Bank initiated coverage of Independence Realty Trust with a rating of Buy and set a new price target of $18.00
B. Riley Securities upgraded Alpha and Omega Semi from Neutral to Buy and set a new price target of $34.00 from $28.00 previously
8-K - INDEPENDENCE REALTY TRUST, INC. (0001466085) (Filer)
424B5 - INDEPENDENCE REALTY TRUST, INC. (0001466085) (Filer)
8-K - INDEPENDENCE REALTY TRUST, INC. (0001466085) (Filer)
BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ:LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced the appointment of Julie Eastland, an experienced biotechnology and financial executive, to Lantheus' Board of Directors ("Board"), effective as of September 3, 2024. As an independent director, Ms. Eastland will serve as a member of the Board's Audit Committee. Following the appointment of Ms. Eastland, the Board will be comprised of ten directors, eight of whom are independent. "We are thrilled to welcome Julie Eastland t
Waives Option to Classify Board Under Maryland Law Independence Realty Trust, Inc. (NYSE:IRT) ("IRT" or the "Company") today announced the appointment of Craig Macnab to its Board of Directors (the "Board"), effective February 29, 2024. Mr. Macnab brings over 20 years of experience to IRT's Board after serving in various executive and board roles in the REIT industry, including most recently as CEO of National Retail Properties, Inc. (NYSE:NNN) for 13 years. Mr. Macnab's appointment increases the size of IRT's Board to 10 members, including 8 independent directors. In connection with this announcement, the Company has entered into a cooperation agreement with Argosy-Lionbridge Management,
Dr. Mike Chang to transition to Executive Chairman and Mr. Stephen Chang to become Chief Executive Officer Alpha and Omega Semiconductor Limited ("AOS") (NASDAQ:AOSL) today announced that its Board of Directors approved a leadership transition plan in which Dr. Mike Chang, currently Chief Executive Officer and Chairman of the Board, will serve as Executive Chairman of AOS, and he will transition the role of Chief Executive Officer to Mr. Stephen Chang, currently the President of AOS. The leadership transition will be effective on March 1, 2023. Dr. Chang founded AOS more than 22 years ago and has led a dedicated and talented team to create and expand one of the most successful and well-re
Independence Realty Trust, Inc. (NYSE:IRT) ("IRT") announced that today IRT's board of directors declared a quarterly dividend of $0.16 per share of IRT common stock, payable on October 18, 2024 to stockholders of record at the close of business on September 30, 2024. About Independence Realty Trust, Inc. Independence Realty Trust, Inc. (NYSE:IRT) is a real estate investment trust that owns and operates multifamily communities, across non-gateway U.S. markets including Atlanta, GA, Dallas, TX, Denver, CO, Columbus, OH, Indianapolis, IN, Raleigh-Durham, NC, Oklahoma City, OK, Nashville, TN, Houston, TX, and Tampa, FL. IRT's investment strategy is focused on gaining scale near major employm
Alpha and Omega Semiconductor Limited ("AOS") (NASDAQ:AOSL) today reported financial results for the fiscal fourth quarter and the fiscal year ended June 30, 2024. The results for the fiscal fourth quarter ended June 30, 2024 were as follows: GAAP Financial Comparison Quarterly (in millions, except percentage and per share data) (unaudited) Three Months Ended June 30, 2024 March 31, 2024 June 30, 2023 Revenue $ 161.3 $ 150.1 $ 161.5 Gross Margin 25.7 %
Achieved record quarterly HEPLISAV-B® net product revenue of $70.2 million, growing 24% year-over-yearReaffirming full year 2024 HEPLISAV-B net product revenue guidance of $265 - $280 millionInitiated dosing in Phase 1/2 trial of novel shingles vaccine program with clinical data expected in 2H 2025Conference call today at 4:30 p.m. ET/1:30 p.m. PTEMERYVILLE, Calif., Aug. 6, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (NASDAQ:DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results and provided a business update for the quarter ended June 30, 2024.
Stifel analyst Tore Svanberg maintains Alpha & Omega (NASDAQ:AOSL) with a Sell and raises the price target from $21 to $36.